Showing results (151-160 of 254) with videos related to
Sort By:
Pageof 26
AIDS (London, England)|December 28, 2017
Changes in insulin sensitivity over time and associated factors in HIV-infected adolescentsMitchell E Geffner, Kunjal Patel, Denise L Jacobson, et al.Journal of the Pediatric Infectious Diseases Society|April 6, 2019
Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 StudyRolando M Viani, Theodore Ruel, Carmelita Alvero, et al.Plos One|August 29, 2022
Competing health risks associated with the COVID-19 pandemic and early response: A scoping reviewStefan Baral, Amrita Rao, Jean Olivier Twahirwa Rwema, et al.Journal of the International AIDS Society|April 9, 2025
Differences in clinical characteristics between adolescents and young adults with perinatally and sexually acquired HIV in the Asia-Pacific regionPhatharajit Phatharodom, Alan Maleesatharn, Tavitiya Sudjaritruk, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 21, 2012
Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapyGeorge K Siberry, D Robert Harris, Ricardo Hugo Oliveira, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 9, 2020
Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1-Exposed Neonates at Risk of Infection (IMPAACT P1110)Diana F Clarke, Edward P Acosta, Mae Cababasay, et al.The Pediatric Infectious Disease Journal|September 10, 2025
Pregnancy Outcomes After HIV Diagnosis in Women Living With HIV in Japan, South Korea and Hong Kong Special Administrative Region: A Brief ReportJunko Tanuma, Awachana Jiamsakul, Jeremy Ross, et al.AIDS (London, England)|September 10, 2020
Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern AfricaPriscilla R Tsondai, Kate Braithwaite, Geoffrey Fatti, et al.American Journal of Epidemiology|April 12, 2012
A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothersPaige L Williams, George R Seage, Russell B Van Dyke, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2010
Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte valueRicardo Oliveira, Margot Krauss, Suzanne Essama-Bibi, et al.Pageof 26